Section Navigation
Elizabeth DeLong, PhD
Elizabeth DeLong is chair of the Duke University Medical Center Department of Biostatistics and Bioinformatics. Her research interests are in the fields of cardiovascular outcomes and quality-of-care research.
A native of Maine, she received BS and MS degrees in mathematics from the University of Maine. She completed her PhD in Biostatistics at the University of North Carolina at Chapel Hill.
DeLong initially joined the Duke faculty as an assistant professor in the Biometry Division of the Department of Community and Family Medicine. She spent time in both the Duke Comprehensive Cancer Center and the Veterans Administration Health Service Research and Development group.
After three years as director of biostatistics at a leading contract research organization, she returned to Duke to manage the Ischemic Heart Disease Patient Outcomes Research Team, becoming the principal investigator in its final year. She has been awarded government funding to study the statistical issues in validating risk prediction models in cardiology and also to study features of managed care affecting quality.
Since 1994 she has served as co-director of the Cardiovascular Outcomes Research group in the Duke Clinical Research Institute (DCRI). She is currently statistical director of the risk modeling and analysis initiatives for three national cardiovascular registry databases. She also sits on several editorial boards and national task forces.
A native of Maine, she received BS and MS degrees in mathematics from the University of Maine. She completed her PhD in Biostatistics at the University of North Carolina at Chapel Hill.
DeLong initially joined the Duke faculty as an assistant professor in the Biometry Division of the Department of Community and Family Medicine. She spent time in both the Duke Comprehensive Cancer Center and the Veterans Administration Health Service Research and Development group.
After three years as director of biostatistics at a leading contract research organization, she returned to Duke to manage the Ischemic Heart Disease Patient Outcomes Research Team, becoming the principal investigator in its final year. She has been awarded government funding to study the statistical issues in validating risk prediction models in cardiology and also to study features of managed care affecting quality.
Since 1994 she has served as co-director of the Cardiovascular Outcomes Research group in the Duke Clinical Research Institute (DCRI). She is currently statistical director of the risk modeling and analysis initiatives for three national cardiovascular registry databases. She also sits on several editorial boards and national task forces.
